Company Search:
Advanced Search
Sponsored Links
Hainan Haiyao Company Limited Company Snapshot
Hainan Haiyao Company Limited operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hainan Haiyao Company Limited with three other companies in this sector in China: Zhejiang Jiuzhou Pharmaceutical Co Ltd (2017 sales of 1.72 billion Chinese Renmimbi [US$253.58 million] of which 92% was Production and sale of chemical active p), Henan Lingrui Pharmaceutical Co., Ltd. (1.85 billion Chinese Renmimbi [US$272.93 million] of which 99% was Health Care), and Tianjin Tianyao Pharmaceutical, Ltd. (1.97 billion Chinese Renmimbi [US$291.12 million] ).

Sales Analysis. During the year ended December of 2017, sales at Hainan Haiyao Company Limited were 1.82 billion Chinese Renmimbi (US$269.39 million). This is an increase of 18.2% versus 2016, when the company's sales were 1.54 billion Chinese Renmimbi. Sales of Other Operating saw an increase that was more than double the company's growth rate: sales were up 222.4% in 2017, from 41.77 million Chinese Renmimbi to 134.67 million Chinese Renmimbi. Hainan Haiyao Company Limited also saw significant increases in sales in Bpc (up 34.1% to 1.40 billion Chinese Renmimbi) and Storage of Chinese Medicine (up 88.7% to 27.97 million Chinese Renmimbi) and Intercompany Eliminations (up 82.0% to 38.73 million Chinese Renmimbi) . Not all segments of Hainan Haiyao Company Limited experienced an increase in sales in 2017: sales of Preparations fell 2.8% to 583.68 million Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hainan Haiyao Company Limited
  Stock Performance Chart for Hainan Haiyao Company Limited
  Stock Data: Recent Stock Performance:
  Current Price (2/15/2019): 5.97
(Figures in Chinese Renmimbi)
1 Week n/a   13 Weeks 7.0%  
4 Weeks -12.2%   52 Weeks n/a  
Hainan Haiyao Company Limited Key Data:
  Ticker: 000566 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2017 Sales 1,824,521,595
(Year Ending Jan 2018).
Employees: 2,350
  Currency: Chinese Renmimbi Market Cap: 7,975,796,206
  Fiscal Yr Ends: December Shares Outstanding: 1,335,979,264
  Share Type: A Gu Closely Held Shares: 660,267,424
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.